Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
Journal of Gastroenterology|May 6, 2017
Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapyKazuhiko Masuda, Atsushi Ono, Hiroshi Aikata, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 11, 2020
Real-world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus-related decompensated cirrhosisKazuki Ohya, Michio Imamura, Yuji Teraoka, et al.
Japanese Journal of Clinical Oncology|October 29, 2023
Comprehensive genomic profiling testing in Japanese castration-resistant prostate cancer patients: results of a single-center retrospective cohort studyTakafumi Fukushima, Keisuke Goto, Tetsutaro Hayashi, et al.
Cancers|September 9, 2023
Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab TreatmentYosuke Tamura, Atsushi Ono, Hikaru Nakahara, et al.
Plos Genetics|April 18, 2013
A nonsynonymous polymorphism in semaphorin 3A as a risk factor for human unexplained cardiac arrest with documented ventricular fibrillationYukiko Nakano, Kazuaki Chayama, Hidenori Ochi, et al.
Liver Cancer|January 29, 2026
Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) versus Atezolizumab plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective StudyKo Hashimoto, Tomokazu Kawaoka, Tomoaki Emori, et al.
Pageof 18